Evofem Biosciences, Inc.
EVFM
$0.0099
$0.00044.21%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.23M | -3.10M | -8.86M | -7.94M | 60.43M |
| Total Depreciation and Amortization | 1.03M | 938.00K | 731.00K | 430.00K | 160.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.73M | -4.74M | 3.38M | -1.77M | -70.52M |
| Change in Net Operating Assets | 1.70M | 3.45M | 867.00K | 7.63M | 6.38M |
| Cash from Operations | -5.23M | -3.45M | -3.89M | -1.65M | -3.55M |
| Capital Expenditure | -2.00K | 0.00 | -14.00K | -14.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -612.00K | -612.00K | -555.00K | -509.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -614.00K | -612.00K | -569.00K | -523.00K | -14.00K |
| Total Debt Issued | 2.81M | 397.00K | 397.00K | 775.00K | 3.90M |
| Total Debt Repaid | -912.00K | -917.00K | -782.00K | -669.00K | -1.41M |
| Issuance of Common Stock | 5.00M | 5.00M | 5.00M | 116.00K | 130.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.26M | 1.26M | 1.26M | 1.26M | -- |
| Repurchase of Preferred Stock | -1.26M | -1.26M | -1.26M | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | 0.00 | 0.00 | 1.00M | 1.00M |
| Cash from Financing | 5.90M | 4.48M | 4.62M | 2.48M | 3.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.00K | 420.00K | 161.00K | 312.00K | 56.00K |